These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 15966755

  • 1. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P, Donahue S, Meeker J, Marathe P.
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.
    Ghim JL, Phuong NTT, Kim MJ, Kim EJ, Song GS, Ahn S, Shin JG, Kim EY.
    Drug Des Devel Ther; 2019; 13():1623-1632. PubMed ID: 31190741
    [Abstract] [Full Text] [Related]

  • 3. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
    Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills DJ.
    Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
    [Abstract] [Full Text] [Related]

  • 4. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult subjects.
    Boulton DW, Smith CH, Li L, Huang J, Tang A, LaCreta FP.
    Clin Drug Investig; 2011 Apr; 31(9):619-30. PubMed ID: 21819160
    [Abstract] [Full Text] [Related]

  • 5. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI, Lee H, Oh J, Lim KS, Jang IJ, Kim JA, Jung JH, Yu KS.
    Drug Des Devel Ther; 2015 Apr; 9():729-36. PubMed ID: 25678778
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lacosamide extended-release capsules are bioequivalent to lacosamide immediate-release tablets: Pharmacokinetic observations and simulations.
    Wheless J, Gidal B, Gong L, Lyu S, Zheng X, Li R, Chang W, Tan M.
    Epilepsy Res; 2024 May; 202():107350. PubMed ID: 38513537
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release.
    Ermer JC, Shojaei A, Pennick M, Anderson CS, Silverberg A, Youcha SH.
    Curr Med Res Opin; 2007 May; 23(5):1067-75. PubMed ID: 17519073
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.
    Murphy J, Wang SS, Stieltjes H, Wajs E, Devineni D.
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):256-64. PubMed ID: 25546166
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjects.
    Gummesson A, Li H, Gillen M, Xu J, Niazi M, Hirshberg B.
    Clin Drug Investig; 2014 Nov; 34(11):763-72. PubMed ID: 25269885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.